Prolonged grief disorder: clinical utility of ICD-11 diagnostic guidelines.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 19 6 2018
medline: 15 5 2020
entrez: 19 6 2018
Statut: ppublish

Résumé

The World Health Organization (WHO) International Classification of Disease (ICD-11) is expected to include a new diagnosis for prolonged grief disorder (ICD-11PGD). This study examines the validity and clinical utility of the ICD-11PGD guideline by testing its performance in a well-characterized clinical sample and contrasting it with a very different criteria set with the same name (PGDPLOS). We examined data from 261 treatment-seeking participants in the National Institute of Mental Health (NIMH)-sponsored multicenter clinical trial to determine the rates of diagnosis using the ICD-11PGD guideline and compared these with diagnosis using PGDPLOS criteria. The ICD-11PGD guideline identified 95.8% [95% confidence interval (CI) 93.3-98.2%] of a treatment-responsive cohort of patients with distressing and impairing grief. PGDPLOS criteria identified only 59.0% (95% CI 53.0-65.0%) and were more likely to omit those who lost someone other than a spouse, were currently married, bereaved by violent means, or not diagnosed with co-occurring depression. Those not diagnosed by PGDPLOS criteria showed the same rate of treatment response as those who were diagnosed. The ICD-11PGD diagnostic guideline showed good performance characteristics in this sample, while PGDPLOS criteria did not. Limitations of the research sample used to derive PGDPLOS criteria may partly explain their poor performance in a more diverse clinical sample. Clinicians and researchers need to be aware of the important difference between these two identically named diagnostic methods.

Sections du résumé

BACKGROUND
The World Health Organization (WHO) International Classification of Disease (ICD-11) is expected to include a new diagnosis for prolonged grief disorder (ICD-11PGD). This study examines the validity and clinical utility of the ICD-11PGD guideline by testing its performance in a well-characterized clinical sample and contrasting it with a very different criteria set with the same name (PGDPLOS).
METHODS
We examined data from 261 treatment-seeking participants in the National Institute of Mental Health (NIMH)-sponsored multicenter clinical trial to determine the rates of diagnosis using the ICD-11PGD guideline and compared these with diagnosis using PGDPLOS criteria.
RESULTS
The ICD-11PGD guideline identified 95.8% [95% confidence interval (CI) 93.3-98.2%] of a treatment-responsive cohort of patients with distressing and impairing grief. PGDPLOS criteria identified only 59.0% (95% CI 53.0-65.0%) and were more likely to omit those who lost someone other than a spouse, were currently married, bereaved by violent means, or not diagnosed with co-occurring depression. Those not diagnosed by PGDPLOS criteria showed the same rate of treatment response as those who were diagnosed.
CONCLUSIONS
The ICD-11PGD diagnostic guideline showed good performance characteristics in this sample, while PGDPLOS criteria did not. Limitations of the research sample used to derive PGDPLOS criteria may partly explain their poor performance in a more diverse clinical sample. Clinicians and researchers need to be aware of the important difference between these two identically named diagnostic methods.

Identifiants

pubmed: 29909789
pii: S0033291718001563
doi: 10.1017/S0033291718001563
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

861-867

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH070741
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH060783
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085297
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085288
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085308
Pays : United States

Auteurs

Christine Mauro (C)

Department of Biostatistics,Mailman School of Public Health, Columbia University,722 West 168th Street, 6th floor, New York, NY 10032,USA.

Charles F Reynolds (CF)

Department of Biostatistics,Mailman School of Public Health, Columbia University,722 West 168th Street, 6th floor, New York, NY 10032,USA.

Andreas Maercker (A)

Department of Biostatistics,Mailman School of Public Health, Columbia University,722 West 168th Street, 6th floor, New York, NY 10032,USA.

Natalia Skritskaya (N)

Department of Biostatistics,Mailman School of Public Health, Columbia University,722 West 168th Street, 6th floor, New York, NY 10032,USA.

Naomi Simon (N)

Department of Biostatistics,Mailman School of Public Health, Columbia University,722 West 168th Street, 6th floor, New York, NY 10032,USA.

Sidney Zisook (S)

Department of Biostatistics,Mailman School of Public Health, Columbia University,722 West 168th Street, 6th floor, New York, NY 10032,USA.

Barry Lebowitz (B)

Department of Biostatistics,Mailman School of Public Health, Columbia University,722 West 168th Street, 6th floor, New York, NY 10032,USA.

Stephen J Cozza (SJ)

Department of Biostatistics,Mailman School of Public Health, Columbia University,722 West 168th Street, 6th floor, New York, NY 10032,USA.

M Katherine Shear (MK)

Department of Biostatistics,Mailman School of Public Health, Columbia University,722 West 168th Street, 6th floor, New York, NY 10032,USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH